2025 Q4 -tulosraportti
58 päivää sitten
‧49 min
Tarjoustasot
First North Sweden
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 2 100 | - | - | ||
| 3 200 | - | - | ||
| 1 629 | - | - | ||
| 1 471 | - | - | ||
| 241 | - | - |
Välittäjätilasto
Dataa ei löytynyt
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q1 -tulosraportti 7.5. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 19.2. | ||
2025 Q2 -tulosraportti 27.8.2025 | ||
2024 Q4 -tulosraportti 14.2.2025 | ||
2024 Q3 -tulosraportti 31.10.2024 | ||
2024 Q2 -tulosraportti 23.8.2024 |
Asiakkaat katsoivat myös
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
·4 t sitten · MuokattuSo we are at the top again on the “growth exchange” https://www.linkedin.com/posts/ugen-p%C3%A5-v%C3%A6kstb%C3%B8rsen-gomspace-danish-aerospace-share-7451231067912650752-tU4z?utm_source=share&utm_medium=member_ios&rcm=ACoAAARpbicBIXyImFWucwSyMHp6NHVIcTURcQs Excerpt “The week on the growth exchange: GomSpace, Danish Aerospace Company A/S, PILA PHARMA etc.💰 It's the weekend, and we can therefore look back at the week's development among the Danish growth exchange companies, where several companies end with large share price increases. GomSpace ends the week with a share price increase of 20% after the company has secured an order of approx. 5,5 mio. euro from Unseenlabs. The two companies already have a collaboration, and the news therefore shows that the collaboration between the two companies continues and grows - and now GomSpace will deliver more microsatellites to be used for maritime surveillance. The satellites are expected to be delivered in the second half of 2027. We continue in the space industry, where Danish Aerospace Company A/S has published its annual report 2025. The company achieved a total revenue of 19 mio. kroner with an EBITDA of -2 mio. kroner. The year was weaker than expected, which is due to delays in contracts and one-off costs. Danish Aerospace Company expects improvement in 2026 with a revenue of 22-25 mio. kroner with an EBITDA of 1-3 mio. kroner. The company has also completed a rights issue, where 8,24 mio. new shares have been issued, which begin trading Monday the 20. April. PILA PHARMA has announced that the unresolved results of XEN-D0501 that we received in January can now be attributed to too low exposure levels. The systematic exposure of the drug in the overweight rats was thus so low that it was not possible to draw conclusions about the effect on body weight or other parameters, which was the best of the possible outcomes. The share price has now risen by 44,5% in the last month after a challenging period. Initiator Pharma has chosen to focus 100% on the company's drug, pudafensine, which is in phase 2. This means that the company is dropping the development of IP2018, and can therefore gather all its resources on pudafensine, which is considered to be the company's best bet. Initiator Pharma can therefore lead to better capital allocation and accelerate partnerships, but naturally also becomes more vulnerable due to lack of diversification. EgnsINVEST Ejendomme Tyskland has published preliminary key figures for the first quarter of 2026, which follow the budget. The first three months of the year show an expected result before fair value adjustments and revaluations (EBVAT) of 3,5 mio. kroner, which aligns with the company's expectations, which remain unchanged in the range of 15-17 mio. kroner for the year. The company also expects a positive adjustment of property values of 2,2 mio. kroner in the first quarter. Among the week's other news, it can be mentioned that Dataproces has entered into a contract with two municipalities on Zealand for the SaaS solution MARS Moms and Data Analysis respectively. Erria A/S will raise new capital by issuing up to 4,59 mio. new shares, which can give the company gross proceeds of approx. 16,1 mio. kroner. Monsenso also raises gross proceeds of 3,2 mio. kroner through a directed share issue.”
·1 päivä sitten · MuokattuFacebook The Military Channel TMC, Ukraine Plans are already underway for the UASAT constellation, a network of approximately 300 communication satellites. While initial manufacturing is taking place with partners such as Denmark's GomSpace, production is planned to move entirely to Ukraine as part of its "Sovereign Digital Defense" strategy. https://www.facebook.com/photo.php?fbid=122202211304902462&set=a.122159720312902462&type=3
·1 päivä sittenThat the board, ahead of the annual general meeting in May 2026, seeks authorization to issue up to 20% more shares is the clearest indication that they want the possibility to quickly raise capital. In combination with the cash flow now being predicted to become negative during 2026, the probability increases that a directed new share issue may occur during the year to finance the aggressive expansion. What do you think·1 päivä sittenThanks for the answer to my question. I do think that the situation this year is very much different now than the years you mentioned. I believe that the very large persona addition and that Gomspace is much more expansive, it will cost significantly more money than in previous years. The question I ask myself is. Will the capital come in at the pace they need it? Doubtful. I should clarify, however, that I do not see a new issue as directly negative
·1 päivä sittenI think we interpret differently what expansion is being indicated (see my post in the other thread). If you are right, and they intend to hire approx. 181 new employees (which I interpret as being your position, correct me if I'm wrong), then I would definitely agree with you that it would significantly increase the chance of a new emission. One of us must remember to ask the question at the Q1 presentation about expectations for new hires :)
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2025 Q4 -tulosraportti
58 päivää sitten
‧49 min
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·4 t sitten · MuokattuSo we are at the top again on the “growth exchange” https://www.linkedin.com/posts/ugen-p%C3%A5-v%C3%A6kstb%C3%B8rsen-gomspace-danish-aerospace-share-7451231067912650752-tU4z?utm_source=share&utm_medium=member_ios&rcm=ACoAAARpbicBIXyImFWucwSyMHp6NHVIcTURcQs Excerpt “The week on the growth exchange: GomSpace, Danish Aerospace Company A/S, PILA PHARMA etc.💰 It's the weekend, and we can therefore look back at the week's development among the Danish growth exchange companies, where several companies end with large share price increases. GomSpace ends the week with a share price increase of 20% after the company has secured an order of approx. 5,5 mio. euro from Unseenlabs. The two companies already have a collaboration, and the news therefore shows that the collaboration between the two companies continues and grows - and now GomSpace will deliver more microsatellites to be used for maritime surveillance. The satellites are expected to be delivered in the second half of 2027. We continue in the space industry, where Danish Aerospace Company A/S has published its annual report 2025. The company achieved a total revenue of 19 mio. kroner with an EBITDA of -2 mio. kroner. The year was weaker than expected, which is due to delays in contracts and one-off costs. Danish Aerospace Company expects improvement in 2026 with a revenue of 22-25 mio. kroner with an EBITDA of 1-3 mio. kroner. The company has also completed a rights issue, where 8,24 mio. new shares have been issued, which begin trading Monday the 20. April. PILA PHARMA has announced that the unresolved results of XEN-D0501 that we received in January can now be attributed to too low exposure levels. The systematic exposure of the drug in the overweight rats was thus so low that it was not possible to draw conclusions about the effect on body weight or other parameters, which was the best of the possible outcomes. The share price has now risen by 44,5% in the last month after a challenging period. Initiator Pharma has chosen to focus 100% on the company's drug, pudafensine, which is in phase 2. This means that the company is dropping the development of IP2018, and can therefore gather all its resources on pudafensine, which is considered to be the company's best bet. Initiator Pharma can therefore lead to better capital allocation and accelerate partnerships, but naturally also becomes more vulnerable due to lack of diversification. EgnsINVEST Ejendomme Tyskland has published preliminary key figures for the first quarter of 2026, which follow the budget. The first three months of the year show an expected result before fair value adjustments and revaluations (EBVAT) of 3,5 mio. kroner, which aligns with the company's expectations, which remain unchanged in the range of 15-17 mio. kroner for the year. The company also expects a positive adjustment of property values of 2,2 mio. kroner in the first quarter. Among the week's other news, it can be mentioned that Dataproces has entered into a contract with two municipalities on Zealand for the SaaS solution MARS Moms and Data Analysis respectively. Erria A/S will raise new capital by issuing up to 4,59 mio. new shares, which can give the company gross proceeds of approx. 16,1 mio. kroner. Monsenso also raises gross proceeds of 3,2 mio. kroner through a directed share issue.”
- ·1 päivä sitten · MuokattuFacebook The Military Channel TMC, Ukraine Plans are already underway for the UASAT constellation, a network of approximately 300 communication satellites. While initial manufacturing is taking place with partners such as Denmark's GomSpace, production is planned to move entirely to Ukraine as part of its "Sovereign Digital Defense" strategy. https://www.facebook.com/photo.php?fbid=122202211304902462&set=a.122159720312902462&type=3
- ·1 päivä sittenThat the board, ahead of the annual general meeting in May 2026, seeks authorization to issue up to 20% more shares is the clearest indication that they want the possibility to quickly raise capital. In combination with the cash flow now being predicted to become negative during 2026, the probability increases that a directed new share issue may occur during the year to finance the aggressive expansion. What do you think·1 päivä sittenThanks for the answer to my question. I do think that the situation this year is very much different now than the years you mentioned. I believe that the very large persona addition and that Gomspace is much more expansive, it will cost significantly more money than in previous years. The question I ask myself is. Will the capital come in at the pace they need it? Doubtful. I should clarify, however, that I do not see a new issue as directly negative·1 päivä sittenI think we interpret differently what expansion is being indicated (see my post in the other thread). If you are right, and they intend to hire approx. 181 new employees (which I interpret as being your position, correct me if I'm wrong), then I would definitely agree with you that it would significantly increase the chance of a new emission. One of us must remember to ask the question at the Q1 presentation about expectations for new hires :)
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
First North Sweden
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 2 100 | - | - | ||
| 3 200 | - | - | ||
| 1 629 | - | - | ||
| 1 471 | - | - | ||
| 241 | - | - |
Välittäjätilasto
Dataa ei löytynyt
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q1 -tulosraportti 7.5. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 19.2. | ||
2025 Q2 -tulosraportti 27.8.2025 | ||
2024 Q4 -tulosraportti 14.2.2025 | ||
2024 Q3 -tulosraportti 31.10.2024 | ||
2024 Q2 -tulosraportti 23.8.2024 |
2025 Q4 -tulosraportti
58 päivää sitten
‧49 min
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q1 -tulosraportti 7.5. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 19.2. | ||
2025 Q2 -tulosraportti 27.8.2025 | ||
2024 Q4 -tulosraportti 14.2.2025 | ||
2024 Q3 -tulosraportti 31.10.2024 | ||
2024 Q2 -tulosraportti 23.8.2024 |
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·4 t sitten · MuokattuSo we are at the top again on the “growth exchange” https://www.linkedin.com/posts/ugen-p%C3%A5-v%C3%A6kstb%C3%B8rsen-gomspace-danish-aerospace-share-7451231067912650752-tU4z?utm_source=share&utm_medium=member_ios&rcm=ACoAAARpbicBIXyImFWucwSyMHp6NHVIcTURcQs Excerpt “The week on the growth exchange: GomSpace, Danish Aerospace Company A/S, PILA PHARMA etc.💰 It's the weekend, and we can therefore look back at the week's development among the Danish growth exchange companies, where several companies end with large share price increases. GomSpace ends the week with a share price increase of 20% after the company has secured an order of approx. 5,5 mio. euro from Unseenlabs. The two companies already have a collaboration, and the news therefore shows that the collaboration between the two companies continues and grows - and now GomSpace will deliver more microsatellites to be used for maritime surveillance. The satellites are expected to be delivered in the second half of 2027. We continue in the space industry, where Danish Aerospace Company A/S has published its annual report 2025. The company achieved a total revenue of 19 mio. kroner with an EBITDA of -2 mio. kroner. The year was weaker than expected, which is due to delays in contracts and one-off costs. Danish Aerospace Company expects improvement in 2026 with a revenue of 22-25 mio. kroner with an EBITDA of 1-3 mio. kroner. The company has also completed a rights issue, where 8,24 mio. new shares have been issued, which begin trading Monday the 20. April. PILA PHARMA has announced that the unresolved results of XEN-D0501 that we received in January can now be attributed to too low exposure levels. The systematic exposure of the drug in the overweight rats was thus so low that it was not possible to draw conclusions about the effect on body weight or other parameters, which was the best of the possible outcomes. The share price has now risen by 44,5% in the last month after a challenging period. Initiator Pharma has chosen to focus 100% on the company's drug, pudafensine, which is in phase 2. This means that the company is dropping the development of IP2018, and can therefore gather all its resources on pudafensine, which is considered to be the company's best bet. Initiator Pharma can therefore lead to better capital allocation and accelerate partnerships, but naturally also becomes more vulnerable due to lack of diversification. EgnsINVEST Ejendomme Tyskland has published preliminary key figures for the first quarter of 2026, which follow the budget. The first three months of the year show an expected result before fair value adjustments and revaluations (EBVAT) of 3,5 mio. kroner, which aligns with the company's expectations, which remain unchanged in the range of 15-17 mio. kroner for the year. The company also expects a positive adjustment of property values of 2,2 mio. kroner in the first quarter. Among the week's other news, it can be mentioned that Dataproces has entered into a contract with two municipalities on Zealand for the SaaS solution MARS Moms and Data Analysis respectively. Erria A/S will raise new capital by issuing up to 4,59 mio. new shares, which can give the company gross proceeds of approx. 16,1 mio. kroner. Monsenso also raises gross proceeds of 3,2 mio. kroner through a directed share issue.”
- ·1 päivä sitten · MuokattuFacebook The Military Channel TMC, Ukraine Plans are already underway for the UASAT constellation, a network of approximately 300 communication satellites. While initial manufacturing is taking place with partners such as Denmark's GomSpace, production is planned to move entirely to Ukraine as part of its "Sovereign Digital Defense" strategy. https://www.facebook.com/photo.php?fbid=122202211304902462&set=a.122159720312902462&type=3
- ·1 päivä sittenThat the board, ahead of the annual general meeting in May 2026, seeks authorization to issue up to 20% more shares is the clearest indication that they want the possibility to quickly raise capital. In combination with the cash flow now being predicted to become negative during 2026, the probability increases that a directed new share issue may occur during the year to finance the aggressive expansion. What do you think·1 päivä sittenThanks for the answer to my question. I do think that the situation this year is very much different now than the years you mentioned. I believe that the very large persona addition and that Gomspace is much more expansive, it will cost significantly more money than in previous years. The question I ask myself is. Will the capital come in at the pace they need it? Doubtful. I should clarify, however, that I do not see a new issue as directly negative·1 päivä sittenI think we interpret differently what expansion is being indicated (see my post in the other thread). If you are right, and they intend to hire approx. 181 new employees (which I interpret as being your position, correct me if I'm wrong), then I would definitely agree with you that it would significantly increase the chance of a new emission. One of us must remember to ask the question at the Q1 presentation about expectations for new hires :)
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
First North Sweden
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 2 100 | - | - | ||
| 3 200 | - | - | ||
| 1 629 | - | - | ||
| 1 471 | - | - | ||
| 241 | - | - |
Välittäjätilasto
Dataa ei löytynyt